Data for: Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits

Name: Data for: Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits
Creator: Ahmet Müderrisoğlu
Published: 2022-01-18T21:18:55.679Z
Keywords: Pharmacogenomics, Genotyping

Müderrisoğlu, Ahmet; Babaoglu, Elif; Korkmaz, Elif Tugce; Kalkisim, Said; Karabulut, Erdem; Emri, Salih; Babaoglu, Melih O.

doi:10.17632/pjf5rdcdf9.1

Data for: Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits

Published: 18 January 2022| Version 1 | DOI: 10.17632/pjf5rdcdf9.1

Contributors:

, Elif Babaoglu, Elif Tugce Korkmaz, Said Kalkisim, Erdem Karabulut, Salih Emri, Melih O. Babaoglu

Description

The data of this manuscript entitled “Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits” by Muderrisoglu et. al., 2022 is presented in this file. In the study, the effects of functional genetic polymorphisms of nicotinic acetylcholine receptor subunits on smoking status and success of cessation treatments in a Turkish population of non-smokers and smokers treated with nicotine replacement, bupropion or varenicline were investigated.

Files

Institutions

Hacettepe Universitesi Tip Fakultesi

Data for: Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits

Description

Files

Institutions

Categories

Licence